|
Volumn 76, Issue 2, 2005, Pages 160-161
|
How can adherence with multi-drug therapy in leprosy be improved?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
TUBERCULOSTATIC AGENT;
BACTERIUM ADHERENCE;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DEVELOPING COUNTRY;
HEALTH CARE COST;
HEALTH EDUCATION;
HEALTH PROGRAM;
HUMAN;
LEPROSY;
MULTIDRUG RESISTANCE;
PUBLIC HEALTH;
ATTITUDE TO HEALTH;
DRUG THERAPY, COMBINATION;
ENDEMIC DISEASES;
FEMALE;
HEALTH EDUCATION;
HUMANS;
INDIA;
LEPROSTATIC AGENTS;
LEPROSY;
MALE;
PATIENT COMPLIANCE;
SEVERITY OF ILLNESS INDEX;
SOUTH AFRICA;
WORLD HEALTH;
|
EID: 22844448666
PISSN: 03057518
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (10)
|
References (11)
|